Impact of Nivolumab Versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients With Advanced Squamous Non-Small Cell Lung Cancer: Results From the CheckMate 017 Study
Journal of Thoracic Oncology (2017), doi: 10.1016/j.jtho.2017.10.029.
Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
Journal of Thoracic Oncology (2017), doi: 10.1016/j.jtho.2017.10.011.
Monthly updates of NSCLC treatment and research from major journals: issue Dec 2017
This article summaries recent progresses published in high impact journals on lung cancer research and treatment. Kindly provided by Ms. Dandan Hu (胡丹丹), a MSI from Roche China, will continually update for every month. Articles in Chinese.
Novel biomarker of lung adenocarcinoma in process of unsaturated fatty acid synthesis
Dr. Elaine Lai-Han Leung et al reported a new biomarker specifically and highly expressed in lung adenocarcinoma indicating poor prognosis.